UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Primary Analysis of the Phase II Component of a Phase I/II Dose Intensification Study Using Three-Dimensional Conformal Radiation Therapy and Concurrent Chemotherapy for Patients With Inoperable Non–Small-Cell Lung Cancer: RTOG 0117

Journal of clinical oncology, 2010-05, Vol.28 (14), p.2475-2480

2010

Volltextzugriff (PDF)

Comorbidity and Karnofksy performance score are independent prognostic factors in stage III non-small-cell lung cancer: An institutional analysis of patients treated on four RTOG studies

International journal of radiation oncology, biology, physics, 2002-10, Vol.54 (2), p.357-364

2002

Volltextzugriff (PDF)

The Effects of Comorbidity and Age on RTOG Study Enrollment in Stage III Non–Small Cell Lung Cancer Patients Who Are Eligible for RTOG Studies

International journal of radiation oncology, biology, physics, 2010-12, Vol.78 (5), p.1394-1399

2010

Volltextzugriff (PDF)

A Phase I/II Radiation Dose Escalation Study With Concurrent Chemotherapy for Patients With Inoperable Stages I to III Non-Small-Cell Lung Cancer: Phase I Results of RTOG 0117

International journal of radiation oncology, biology, physics, 2010-06, Vol.77 (2), p.367-372

2010

Volltextzugriff (PDF)

MDM2 and Ki-67 Predict for Distant Metastasis and Mortality in Men Treated With Radiotherapy and Androgen Deprivation for Prostate Cancer: RTOG 92-02

Journal of clinical oncology, 2009-07, Vol.27 (19), p.3177-3184

2009

Volltextzugriff (PDF)

Effect of overall treatment time on outcomes after concurrent chemoradiation for locally advanced non–small-cell lung carcinoma: Analysis of the Radiation Therapy Oncology Group (RTOG) experience

International journal of radiation oncology, biology, physics, 2005-11, Vol.63 (3), p.667-671

2005

Volltextzugriff (PDF)

Randomized Trial of Amifostine in Locally Advanced Non–Small-Cell Lung Cancer Patients Receiving Chemotherapy and Hyperfractionated Radiation: Radiation Therapy Oncology Group Trial 98-01

Journal of clinical oncology, 2005-04, Vol.23 (10), p.2145-2154

2005

Volltextzugriff (PDF)

Common toxicity criteria: version 2.0. an improved reference for grading the acute effects of cancer treatment: impact on radiotherapy

International journal of radiation oncology, biology, physics, 2000-04, Vol.47 (1), p.13-47

2000

Volltextzugriff (PDF)

Comorbidity and KPS are independent prognostic factors in stage I non-small-cell lung cancer

International journal of radiation oncology, biology, physics, 2002-03, Vol.52 (4), p.1047-1057

2002

Volltextzugriff (PDF)

Recursive partitioning analysis (RPA) of prognostic factors in three radiation therapy oncology group (RTOG) brain metastases trials

International journal of radiation oncology, biology, physics, 1997-03, Vol.37 (4), p.745-751

1997

Volltextzugriff (PDF)

Phase III study comparing chemotherapy and radiotherapy with preoperative chemotherapy and surgical resection in patients with non-small-cell lung cancer with spread to mediastinal lymph nodes (N2); final report of RTOG 89-01

International journal of radiation oncology, biology, physics, 2002-10, Vol.54 (2), p.365-369

2002

Volltextzugriff (PDF)

Phase I study of thoracic radiation dose escalation with concurrent chemotherapy for patients with limited small-cell lung cancer: Report of Radiation Therapy Oncology Group (RTOG) protocol 97–12

International journal of radiation oncology, biology, physics, 2005-06, Vol.62 (2), p.342-350

2005

Volltextzugriff (PDF)

Recursive partitioning analysis of 1999 radiation therapy oncology group (RTOG) patients with locally-advanced non–small-cell lung cancer (LA-NSCLC): Identification of five groups with different survival

International journal of radiation oncology, biology, physics, 2000-12, Vol.48 (5), p.1475-1482

2000

Volltextzugriff (PDF)

The Importance of Protein Kinase A in Prostate Cancer: Relationship to Patient Outcome in Radiation Therapy Oncology Group Trial 92-02

Clinical cancer research, 2009-09, Vol.15 (17), p.5478-5484

2009

Volltextzugriff (PDF)

Elective Lymph Node Irradiation With Intensity-Modulated Radiotherapy: Is Conventional Dose Fractionation Necessary?

International journal of radiation oncology, biology, physics, 2012-05, Vol.83 (1), p.e87-e92

2012

Volltextzugriff (PDF)

Study of Paclitaxel, Etoposide, and Cisplatin Chemotherapy Combined With Twice-Daily Thoracic Radiotherapy for Patients With Limited-Stage Small-Cell Lung Cancer: A Radiation Therapy Oncology Group 9609 Phase II Study

Journal of clinical oncology, 2005-08, Vol.23 (22), p.4991-4998

2005

Volltextzugriff (PDF)

Clinically Meaningful Differences in Patient-Reported Outcomes With Amifostine in Combination With Chemoradiation for Locally Advanced Non–Small-Cell Lung Cancer: An Analysis of RTOG 9801

International journal of radiation oncology, biology, physics, 2008-12, Vol.72 (5), p.1378-1384

2008

Volltextzugriff (PDF)

Anal sphincter conservation for patients with adenocarcinoma of the distal rectum: long-term results of radiation therapy oncology group protocol 89-02

International journal of radiation oncology, biology, physics, 2000-01, Vol.46 (2), p.313-322

2000

Volltextzugriff (PDF)

Does Response to Induction Chemotherapy Predict Survival for Locally Advanced Non–Small-Cell Lung Cancer? Secondary Analysis of RTOG 8804/8808

International journal of radiation oncology, biology, physics, 2010-03, Vol.76 (3), p.802-808

2010

Volltextzugriff (PDF)

Age is independent of comorbidity influencing patient selection for combined modality therapy for treatment of stage III nonsmall cell lung cancer (NSCLC)

American journal of clinical oncology, 2006-06, Vol.29 (3), p.252-257

2006

Volltextzugriff (PDF)

Addition of chemotherapy to radiation therapy alters failure patterns by cell type within non-small cell carcinoma of lung (NSCCL): analysis of radiation therapy oncology group (RTOG) trials

International journal of radiation oncology, biology, physics, 1999-02, Vol.43 (3), p.505-509

1999

Volltextzugriff (PDF)

Interruptions of high-dose radiation therapy decrease longterm survival of favorable patients with unresectable nonsmall cell carcinoma of the lung: analysis of 1244 cases from 3 radiation therapy oncology group (RTOG) trials

International journal of radiation oncology, biology, physics, 1993-10, Vol.27 (3), p.493-498

1993

Volltextzugriff (PDF)

Do “elderly fit” patients have less comorbidity?

International journal of radiation oncology, biology, physics, 2003-04, Vol.55 (5), p.1166-1168

2003

Volltextzugriff (PDF)

Acute Esophagitis and Late Lung Toxicity in Concurrent Chemoradiotherapy Trials in Patients with Locally Advanced Non–Small-Cell Lung Cancer: Analysis of the Radiation Therapy Oncology Group (RTOG) Database

Clinical lung cancer, 2011-07, Vol.12 (4), p.245-251

2011

Volltextzugriff (PDF)

Microvessel density >or=60 does not predict for outcome after radiation treatment for locally advanced head and neck squamous cell carcinoma: results of a correlative study from the Radiation Therapy Oncology Group (RTOG) 90-03 Trial

American journal of clinical oncology, 2007-08, Vol.30 (4), p.406-419

2007

Volltextzugriff (PDF)

1 – 25 von 160

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(158)
Mit Volltextzugriff
(147)

Publikationsform

Artikel
(159)
Buchkapitel
(1)

Sprache

Englisch
(159)
Französisch
(1)

Erscheinungsjahr

n.n

Thema

Humans
(109)
Life Sciences & Biomedicine
(101)
Science & Technology
(101)
Oncology
(85)
Male
(76)
Middle Aged
(66)
Biological And Medical Sciences
(65)
Medical Sciences
(65)
Female
(60)
Radiology, Nuclear Medicine & Medical Imaging
(57)
Lung Neoplasms - Radiotherapy
(52)
Aged
(49)
Combined Modality Therapy
(40)
Carcinoma, Non-Small-Cell Lung - Radiotherapy
(38)
Radiotherapy Dosage
(37)
Lung Neoplasms - Drug Therapy
(33)
Pneumology
(28)
Tumors Of The Respiratory System And Mediastinum
(28)
Adult
(27)
Carcinoma, Squamous Cell - Radiotherapy
(27)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Primary Analysis of the Phase II Component of a Phase I/II Dose Intensification Study Using Three-Dimensional Conformal Radiation Therapy and Concurrent Chemotherapy for Patients With Inoperable Non–Small-Cell Lung Cancer: RTOG 0117

Comorbidity and Karnofksy performance score are independent prognostic factors in stage III non-small-cell lung cancer: An institutional analysis of patients treated on four RTOG studies

The Effects of Comorbidity and Age on RTOG Study Enrollment in Stage III Non–Small Cell Lung Cancer Patients Who Are Eligible for RTOG Studies

A Phase I/II Radiation Dose Escalation Study With Concurrent Chemotherapy for Patients With Inoperable Stages I to III Non-Small-Cell Lung Cancer: Phase I Results of RTOG 0117

MDM2 and Ki-67 Predict for Distant Metastasis and Mortality in Men Treated With Radiotherapy and Androgen Deprivation for Prostate Cancer: RTOG 92-02

Effect of overall treatment time on outcomes after concurrent chemoradiation for locally advanced non–small-cell lung carcinoma: Analysis of the Radiation Therapy Oncology Group (RTOG) experience

Randomized Trial of Amifostine in Locally Advanced Non–Small-Cell Lung Cancer Patients Receiving Chemotherapy and Hyperfractionated Radiation: Radiation Therapy Oncology Group Trial 98-01

Common toxicity criteria: version 2.0. an improved reference for grading the acute effects of cancer treatment: impact on radiotherapy

Comorbidity and KPS are independent prognostic factors in stage I non-small-cell lung cancer

Recursive partitioning analysis (RPA) of prognostic factors in three radiation therapy oncology group (RTOG) brain metastases trials

Phase III study comparing chemotherapy and radiotherapy with preoperative chemotherapy and surgical resection in patients with non-small-cell lung cancer with spread to mediastinal lymph nodes (N2); final report of RTOG 89-01

Phase I study of thoracic radiation dose escalation with concurrent chemotherapy for patients with limited small-cell lung cancer: Report of Radiation Therapy Oncology Group (RTOG) protocol 97–12

Recursive partitioning analysis of 1999 radiation therapy oncology group (RTOG) patients with locally-advanced non–small-cell lung cancer (LA-NSCLC): Identification of five groups with different survival

The Importance of Protein Kinase A in Prostate Cancer: Relationship to Patient Outcome in Radiation Therapy Oncology Group Trial 92-02

Elective Lymph Node Irradiation With Intensity-Modulated Radiotherapy: Is Conventional Dose Fractionation Necessary?

Study of Paclitaxel, Etoposide, and Cisplatin Chemotherapy Combined With Twice-Daily Thoracic Radiotherapy for Patients With Limited-Stage Small-Cell Lung Cancer: A Radiation Therapy Oncology Group 9609 Phase II Study

Clinically Meaningful Differences in Patient-Reported Outcomes With Amifostine in Combination With Chemoradiation for Locally Advanced Non–Small-Cell Lung Cancer: An Analysis of RTOG 9801

Anal sphincter conservation for patients with adenocarcinoma of the distal rectum: long-term results of radiation therapy oncology group protocol 89-02

Does Response to Induction Chemotherapy Predict Survival for Locally Advanced Non–Small-Cell Lung Cancer? Secondary Analysis of RTOG 8804/8808

Age is independent of comorbidity influencing patient selection for combined modality therapy for treatment of stage III nonsmall cell lung cancer (NSCLC)

Addition of chemotherapy to radiation therapy alters failure patterns by cell type within non-small cell carcinoma of lung (NSCCL): analysis of radiation therapy oncology group (RTOG) trials

Interruptions of high-dose radiation therapy decrease longterm survival of favorable patients with unresectable nonsmall cell carcinoma of the lung: analysis of 1244 cases from 3 radiation therapy oncology group (RTOG) trials

Do “elderly fit” patients have less comorbidity?

Acute Esophagitis and Late Lung Toxicity in Concurrent Chemoradiotherapy Trials in Patients with Locally Advanced Non–Small-Cell Lung Cancer: Analysis of the Radiation Therapy Oncology Group (RTOG) Database

Microvessel density >or=60 does not predict for outcome after radiation treatment for locally advanced head and neck squamous cell carcinoma: results of a correlative study from the Radiation Therapy Oncology Group (RTOG) 90-03 Trial

Suchergebnisse filtern